Published in J Virol on June 01, 1984
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med (1986) 2.89
Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J Virol (1986) 1.23
Activated B cells can deliver help for the in vitro generation of antiviral cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 1.19
In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol (1990) 1.11
Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J Exp Med (1990) 0.99
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Direct role of viral hemagglutinin in B-cell mitogenesis by influenza viruses. J Virol (1987) 0.78
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med (1966) 9.26
Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. Virology (1979) 2.66
Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology (1983) 2.27
Functional heterogeneity among the T-derived lymphocytes of the mouse. III. Helper and suppressor T-cells activated by concanavalin A. Cell Immunol (1975) 1.30
In vitro mitogenic stimulation of murine spleen cells by herpes simplex virus. J Immunol (1978) 1.24
Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature (1978) 1.20
Lymphocyte receptors for myxoviruses and paramyxoviruses. J Immunol (1974) 1.04
Activation of mouse lymphocytes by vesicular stomatitis virus. J Virol (1980) 1.04
The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus. J Exp Med (1977) 1.01
In vitro antibody response to influenza virus. I. T cell dependence of secondary response to hemagglutinin. J Immunol (1979) 1.01
Viruses as nonspecific modulators of immunological reactivity. Acta Virol (1981) 0.97
Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect Immun (1983) 0.95
Mitogenic activity of Sindbis virus and its isolated glycoproteins. Infect Immun (1982) 0.90
Influenza A virus interaction with murine lymphocytes. III. Recirculating rat T and B cells differ on the basis of receptors for Cam (H1N1) virus. Cell Immunol (1981) 0.80
The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology (1968) 7.42
The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion. Virology (1968) 4.19
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 2.63
Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol (1997) 2.18
The structural proteins of Newcastle disease virus. Virology (1969) 1.99
CD1d-restricted NKT cells: an interstrain comparison. J Immunol (2001) 1.88
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol (1999) 1.83
Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol (1997) 1.82
Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest (1993) 1.80
The polypeptides of adenovirus. 3. Synthesis in infected cells. Virology (1969) 1.77
Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J Virol (1992) 1.56
Cytotoxic macrophages: a rapid nonspecific response to viral infection. J Immunol (1976) 1.48
Inhibition of influenza viral glycoprotein synthesis by sugars. Microbios (1972) 1.46
Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45
Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol (1977) 1.37
Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol (1998) 1.28
Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant (2001) 1.26
Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrob Agents Chemother (1992) 1.25
Donovanosis in Papua New Guinea. Br J Vener Dis (1976) 1.25
Antigenic determinants of influenza virus hemagglutinin. II. Antigenic reactivity of the isolated N-terminal cyanogen bromide peptide of A/Memphis/72 hemagglutinin heavy chain. Virology (1979) 1.23
Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J Virol (1986) 1.23
The polypeptides of influenza virus. VI. Composition of the neuraminidase. Virology (1972) 1.22
Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. Mol Immunol (1985) 1.20
Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics (2001) 1.18
Early events in the eclipse phase of influenza and parainfluenza virus infection. Virology (1966) 1.18
Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci U S A (1998) 1.18
The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev (1997) 1.15
Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1. Virology (1986) 1.13
A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics (1997) 1.13
In vitro antibody response to influenza virus. II. Specificity of helper T cell recognizing hemagglutinin. J Immunol (1981) 1.13
Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. J Immunol (1988) 1.12
The polypeptides of influenza virus. 1. Cytoplasmic synthesis and nuclear accumulation. Virology (1969) 1.12
Herpes simplex virus infection of the cornea. Med J Aust (1968) 1.11
Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol (1996) 1.07
Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol (1993) 1.07
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J Immunol (1996) 1.07
NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J Immunol (2001) 1.05
The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci U S A (1999) 1.05
An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch Virol (1990) 1.04
Cell-mediated immunity to viruses measured by the indirect agarose technique of leukocyte migration inhibition. Cell Immunol (1976) 1.04
The polypeptides of influenza virus. IV. An analysis of nuclear accumulation. Virology (1970) 1.04
The polypeptides of influenza virus. 3. Identification of the hemagglutinin, neuraminidase and nucleocapsid proteins. Virology (1970) 1.04
Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus. Virology (1994) 1.03
Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun (2003) 1.02
In vitro antibody response to influenza virus. I. T cell dependence of secondary response to hemagglutinin. J Immunol (1979) 1.01
Antigenic determinants of influenza virus hemagglutinin. III. Competitive binding of antibodies directed against "common" and "strain-specific" antigenic determinants of A/Memphis/72 hemagglutinin. J Immunol (1979) 1.01
Identification of the glycoprotein H gene of murine cytomegalovirus. J Gen Virol (1992) 1.00
Influenza viruses as lymphocyte mitogens. I. B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes is controlled by the I-E/C subregion of the major histocompatibility complex. J Immunol (1985) 1.00
Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods (1988) 0.99
The polypeptides of influenza virus. VII. Synthesis of the hemagglutinin. Virology (1973) 0.99
Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains. J Immunol (1985) 0.97
Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes. J Immunol (1985) 0.97
Localization on a physical map of the NKC-linked Cmv1 locus between Ly49b and the Prp gene cluster on mouse chromosome 6. J Immunol (1999) 0.97
Herpes-simplex virus from trigeminal ganglion. Lancet (1973) 0.96
Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus. J Gen Virol (1994) 0.94
The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics (1997) 0.94
Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis (1999) 0.94
Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin. J Virol (1988) 0.94
Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin. J Virol (1988) 0.94
A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun (1995) 0.93
Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Mol Pharmacol (1993) 0.93
Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol (1996) 0.92
The murine cytomegalovirus (MCMV) homolog of the HCMV phosphotransferase (UL97(pk)) gene. Virology (1997) 0.91
Visual acuity of the killer whale (Orcinus orca). Exp Neurol (1971) 0.91
Antigenic determinants of influenza virus hemagglutinin. IV. Immunogenicity of fragments isolated from the hemagglutinin of A/Memphis/72. J Immunol (1979) 0.90
Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J Exp Med (1998) 0.90
Enumeration of antigenic sites of influenza virus hemagglutinin. Infect Immun (1982) 0.90
The polypeptides of influenza virus. II. Interpretation of polyacrylamide gel electrophoresis patterns. Virology (1970) 0.90
Simultaneous binding of two monoclonal antibodies to epitopes separated in sequence by only three amino acid residues. Mol Immunol (1988) 0.89
Induction of immune response to influenza virus with anti-idiotypic antibodies. J Virol (1989) 0.88
Stimulation of Sendai virus multiplication by puromycin and actinomycin D. Nature (1965) 0.88
Microbial communities in the saturated groundwater environment II: Diversity of bacterial communities in a Pleistocene sand aquifer and their in vitro activities. Microb Ecol (1988) 0.88
Antigenic determinants of influenza virus haemagglutinin. VI. Antigenic characterization of the oligosaccharide sidechains form HA1 of influenza virus haemagglutinins. J Gen Virol (1981) 0.87
Mitogenic activity of influenza virus and haemagglutinin. Vaccine (1985) 0.85
A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo. Immunology (1994) 0.85
Antiviral activity of bovine collectins against rotaviruses. J Gen Virol (1998) 0.85
Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy. Clin Exp Immunol (1977) 0.83
Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems. Vaccine (1999) 0.83
Antigenic determinants of influenza virus hemagglutinin. V. Antigenicity of the HA2 chain. J Immunol (1980) 0.83
Antigenic activity of a synthetic peptide comprising the "loop" region of influenza virus hemagglutinin. Virology (1982) 0.83
Further characterization of natural killer cells induced by Kunjin virus. Aust J Exp Biol Med Sci (1980) 0.82
Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition. J Gen Virol (1996) 0.82
Minimum requirements for immunogenic and antigenic activities of homologs of a synthetic peptide of influenza virus hemagglutinin. J Virol (1988) 0.81
Mapping and transcriptional analysis of the murine cytomegalovirus homologue of the human cytomegalovirus UL103 open reading frame. Virology (1994) 0.81
Adenovirus and intussusception. Med J Aust (1966) 0.81